Cargando…
Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator
Tumor genetic heterogeneity may underlie poor clinical outcomes because diverse subclones could be comprised of metastatic and drug resistant cells. Targeted deep sequencing has been used widely as a diagnostic tool to identify actionable mutations in cancer patients. In this study, we evaluated the...
Autores principales: | Oh, Bo Young, Shin, Hyun-Tae, Yun, Jae Won, Kim, Kyu-Tae, Kim, Jinho, Bae, Joon Seol, Cho, Yong Beom, Lee, Woo Yong, Yun, Seong Hyeon, Park, Yoon Ah, Park, Yeon Hee, Im, Young-Hyuck, Lee, Jeeyun, Joung, Je-Gun, Kim, Hee Cheol, Park, Woong-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418103/ https://www.ncbi.nlm.nih.gov/pubmed/30872730 http://dx.doi.org/10.1038/s41598-019-41098-0 |
Ejemplares similares
-
Molecular Characterization of Colorectal Signet-Ring Cell Carcinoma Using Whole-Exome and RNA Sequencing()()
por: Nam, Jae-Yong, et al.
Publicado: (2018) -
Assessment of intratumoral heterogeneity with mutations and gene expression profiles
por: Sung, Ji-Yong, et al.
Publicado: (2019) -
The role of PDGFRA as a therapeutic target in young colorectal cancer patients
por: Kim, Tae Won, et al.
Publicado: (2021) -
The Clinicopathologic Features and Treatment of 607 Hindgut Neuroendocrine Tumor (NET) Patients at a Single Institution
por: Kim, Seung Tae, et al.
Publicado: (2016) -
Prevalence and detection of low-allele-fraction variants in clinical cancer samples
por: Shin, Hyun-Tae, et al.
Publicado: (2017)